Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01646580Phase 4Terminated
A Phase 4 trial of ciclopirox in dermatomycosis, sponsored by Ferrer. Started Oct 2008; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01646580.